Tandem Diabetes Care (TNDM) Profit After Tax (2013 - 2026)
Tandem Diabetes Care (TNDM) reported Profit After Tax of -$20.4 million for Q1 2026, up 84.38% on a YoY basis from -$11.1 million in Q1 2025, and down 3362.31% quarter-over-quarter from -$589000.0 in Q4 2025.
Tandem Diabetes Care (TNDM) Profit After Tax (2013 - 2026) Analysis & Trends
Tandem Diabetes Care has reported Profit After Tax for 14 years, with the latest figure at -$20.4 million in Q1 2026.
- For the quarter ending Q1 2026, Profit After Tax rose 84.38% year-over-year to -$20.4 million; the trailing twelve-month figure through Mar 2026 stood at -$94.5 million (up 48.58% YoY), and the FY2025 full-year result was -$204.7 million, down 113.18% from the prior year.
- Profit After Tax for Q1 2026 stood at -$20.4 million, down from -$589000.0 in the prior quarter.
- The five-year high for Profit After Tax was $755000.0 in Q4 2024, with the low at -$130.6 million in Q1 2025.
- Historically, Profit After Tax has averaged -$37.5 million across 5 years, with a median of -$30.0 million in 2023.
- Annual changes were most pronounced in 2022 — Profit After Tax tumbled 945.18% — and 2024, when it surged 102.52%.
- Tandem Diabetes Care's Profit After Tax stood at -$15.9 million in 2022, then slumped by 89.26% to -$30.0 million in 2023, then soared by 102.52% to $755000.0 in 2024, then sank by 178.01% to -$589000.0 in 2025, then sank by 3362.31% to -$20.4 million in 2026.
- The last three Profit After Tax figures came in at -$20.4 million (Q1 2026), -$589000.0 (Q4 2025), and -$21.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 1.14 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 380.70 Mn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 411.00 Mn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 170.93 Mn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 199.50 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 220.30 Mn |
| 10 | Tandem Diabetes Care | 1.13 Bn | 557.61 Mn | 136.79 Mn | -20.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -20.39 Mn |
| Dec 31, 2025 | -589,000.00 |
| Sep 30, 2025 | -21.17 Mn |
| Jun 30, 2025 | -52.40 Mn |
| Mar 31, 2025 | -130.56 Mn |
| Dec 31, 2024 | 755,000.00 |
| Sep 30, 2024 | -23.25 Mn |
| Jun 30, 2024 | -30.81 Mn |
| Mar 31, 2024 | -42.72 Mn |
| Dec 31, 2023 | -30.00 Mn |
| Sep 30, 2023 | -32.96 Mn |
| Jun 30, 2023 | -35.78 Mn |
| Mar 31, 2023 | -123.87 Mn |
| Dec 31, 2022 | -15.85 Mn |
| Sep 30, 2022 | -48.97 Mn |
| Jun 30, 2022 | -15.06 Mn |
| Mar 31, 2022 | -14.72 Mn |
| Dec 31, 2021 | 10.81 Mn |
| Sep 30, 2021 | 5.79 Mn |
| Jun 30, 2021 | 4.01 Mn |